Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Simple Measures to Reduce Bloodstream Infections Successful After 3 Years
Link ID 22286
Title Simple Measures to Reduce Bloodstream Infections Successful After 3 Years
Url http://www.medscape.com/viewarticle/716589?src=rss
Description ICUs that participated in an 18-month project to reduce catheter-related bloodstream infections continued to show significantly reduced infection rates 18 months after the initial project ended. Medscape Medical News
Category Articles > Business of Medicine
Keywords
Date Feb 9, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Can I Sue if I Am Bullied at Work?
  Do nurses who are bullied in the workplace have any legal recourse? Medscape Nurses
Category:   Articles > Business of Medicine


2. Magellan Health Q3 Profit Beats Street
  Magellan Health Services Inc, which provides a network of doctors and hospitals to its members, posted a quarterly profit that beat market expectations, and reaffirmed its 2008 outlook. Reuters Health Information
Category:   Articles > Business of Medicine


3. Changes in Cervical Cancer Screening Guidelines Could be Cost-Effective
  Now that vaccines and DNA testing for human papillomavirus are available, changes to the current cervical cancer screening guidelines could be cost-effective. Medscape Medical News
Category:   Articles > Business of Medicine


4. Merck Agrees to Pay $4.85 Bln in Vioxx Settlement
  Merck & Co has agreed to pay $4.85 billion to settle claims that its painkiller Vioxx caused heart attacks and strokes in thousands of users, the drugmaker said on Friday. Reuters Health Information
Category:   Articles > Business of Medicine


5. Recentin Fails Lung Cancer Trial
  A clinical trial of Recentin as a treatment for non-small-cell lung cancer has been halted by AstraZeneca, Plc, after a mid-stage study failed to meet its main goal, although trials in colorectal cancer will move ahead. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS